NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration - Slideshow By Nebula Condor · March 19, 2026 · 1 min read nbpsa transcripts Source: seekingalpha.com